- $703.72m
- $1.22bn
- $1.24bn
- 75
- 43
- 44
- 53
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,303 | 415 | 507 | 1,127 | 1,239 |
Cost of Revenue | |||||
Gross Profit | 90.5 | -116 | -46.9 | 69 | 109 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,247 | 758 | 574 | 1,077 | 1,148 |
Operating Profit | 55.6 | -343 | -66.7 | 49.9 | 91.1 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 26.1 | -361 | -95.1 | 34.6 | 43.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 19.1 | -375 | -93.3 | 24.6 | 24.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 22 | -374 | -92.7 | 23.2 | 16 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 20.6 | -378 | -102 | 11.1 | 6.24 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.63 | -11.6 | -4.84 | -0.022 | 0.366 |
Dividends per Share |